• Avidity Biosciences Gets $35M in Immunology R&D Deal with Eli Lilly

    Xconomy San Diego — … Eli Lilly (NYSE: LLY) is paying Avidity $20 million upfront—plus $15 million in equity—for the rights to use the La Jolla, CA, …

    Read More
  • 0 0